Effects of GLP-1 Receptor Agonist on Chronic Axonal Damage, Neurodegeneration, and Cognitive Function in Relapsing-remitting MS (MSGLP): Exploratory, Open Label, Randomized Controlled Trial

Authors
Category Primary study
JournalNEUROTHERAPEUTICS
Year 2024
This article has no abstract
Epistemonikos ID: deac9a5a37a31655c3087a5adc65b279aee7283f
First added on: Feb 19, 2025